{"version":"1.0","provider_name":"EnterpriseAM Egypt","provider_url":"https:\/\/enterpriseam.com\/egypt","author_name":"enterpriseam admin","author_url":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/","title":"Rameda acquires new molecule, Dana gas isn\u2019t complaining","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"7OX36rVwJI\"><a href=\"https:\/\/enterpriseam.com\/egypt\/2021\/07\/15\/rameda-acquires-new-molecule-dana-gas-isnt-complaining\/\">Rameda acquires new molecule, Dana gas isn\u2019t complaining<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/enterpriseam.com\/egypt\/2021\/07\/15\/rameda-acquires-new-molecule-dana-gas-isnt-complaining\/embed\/#?secret=7OX36rVwJI\" width=\"600\" height=\"338\" title=\"&#8220;Rameda acquires new molecule, Dana gas isn\u2019t complaining&#8221; &#8212; EnterpriseAM Egypt\" data-secret=\"7OX36rVwJI\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/enterpriseam.com\/egypt\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"EGX-listed Rameda Pharma has acquired an new anticoagulant molecule, the company said in a press release this morning (pdf). The company didn\u2019t name the molecule, but said the acquisition was part of its strategy to grow its portfolio by buying drugs with \u201can established market presence.\u201d The company said the acquisition will be its largest [&hellip;]"}